Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Immunologic reconstitution after allogeneic stem cell transplant].

João Forjaz de Lacerda1

  • 1Serviço de Hematologia, Hospital de Santa Maria, Faculdade de Medicina, Lisboa.

Acta Medica Portuguesa
|October 4, 2005
PubMed
Summary

Allogeneic stem cell transplant recipients face prolonged immunodeficiency, with slow B- and T-cell recovery impacting infection risk. Accelerating immune reconstitution is vital for reducing transplant mortality.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Case report: VEXAS syndrome: an atypical indolent presentation as sacroiliitis with molecular response to azacitidine.

Frontiers in immunology·2024
Same author

Disseminated intravascular coagulation score evolution in 48 h predicts early death in acute promyelocytic leukemia patients.

European journal of haematology·2024
Same author

Predictors of very early death in acute promyelocytic leukemia: a retrospective real-world cohort study.

Annals of hematology·2023
Same author

Chronic myeloproliferative diseases.

Handbook of clinical neurology·2013
Same author

Invasive fungal disease: challenges in diagnosis and treatment. Foreword.

Clinical drug investigation·2013
Same author

[Biosimilars in oncology].

Acta medica portuguesa·2009

Area of Science:

  • Immunology
  • Transplantation Medicine
  • Cellular Therapy

Context:

  • Allogeneic stem cell transplantation (SCT) leads to prolonged post-transplant immunodeficiency, extending beyond one year.
  • Neutrophil and NK cell recovery is typically rapid (within 2 months), but B- and T-cell reconstitution is significantly delayed.
  • Immune recovery is influenced by recipient age, T-cell depletion strategies, and graft-versus-host disease (GvHD).

Purpose:

  • To summarize the challenges in immune reconstitution following allogeneic SCT.
  • To highlight factors affecting T-cell and B-cell recovery, including thymopoiesis.
  • To underscore the need for strategies to accelerate immune reconstitution and reduce opportunistic infections.

Summary:

  • Immune reconstitution after allogeneic SCT is slow, particularly for B- and T-lymphocytes, which is linked to thymopoiesis.

Related Experiment Videos

  • Delayed T-cell recovery is observed in adult patients, those with extensive chronic GvHD, and recipients of T-cell depleted grafts.
  • The prolonged immunodeficiency increases the risk of opportunistic infections, necessitating new therapeutic approaches.

    • Impact:

    • Development of novel strategies, such as adoptive cellular immunotherapy with donor leukocytes, is crucial for boosting the recipient's immune system.
    • Investigating agents like interleukin-7 and keratinocyte growth factor may enhance thymopoiesis and stimulate immune reconstitution.
    • Accelerating immune reconstitution post-SCT can potentially reduce transplant-related mortality and improve patient outcomes.